查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363222

臨床微生物學市場規模、佔有率、趨勢分析報告：按產品、按疾病、按地區、細分市場趨勢，2023-2030

Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Disease (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 94 Pages | 商品交期: 2-10個工作天內

價格

臨床微生物學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球臨床微生物學市場規模預計將達到76億美元，預測期內年複合成長率為7.1%。

預計在預測期內年複合成長率為 6.7%。臨床微生物學依賴技術和熟練的勞動力來處理臨床檢體和解釋結果。臨床工作人員因測試週轉時間 (TAT) 不佳而感到沮喪。然而，隨著技術的進步，許多測試儀器和設備正在被自動化設備取代，以最大限度地減少人為錯誤和對技術純熟勞工的依賴。

此外，自動化還具有諸如更快的 TAT 以及減少勞動力和實驗室空間使用等優點，從而可以降低與這些測試相關的整體成本。每個製造商都專注於引入自動化檢體處理、板讀取和生物鑒定。 GE Healthcare、PerkinElmer 和 Thermo Fisher 是診斷產業提供自動化系統的主要企業。

院內感染（HAI）的增加也推動了對臨床微生物學診斷和監測的需求。隨著高所得國家加強控制醫院感染，低收入和中等收入國家也意識到了這個威脅。自動化系統和創新設計的引入預計將在預測期內加劇市場競爭並改變市場動態。

世界衛生組織 (WHO) 在 HAI 發病率在 2.5% 至 14.8% 之間的國家尤其活躍，包括衣索比亞、布吉納法索、奈及利亞、阿爾及利亞和塞內加爾。因此，這些國家對 HAI 診斷的需求正在增加。印度、斯里蘭卡、巴基斯坦和不丹等國家也積極參與 HAI 意識計畫。預計印度和中國將成為未來幾年推動 HAI 診斷設備和測試需求的主要國家。

臨床微生物學市場報告亮點

  • 預計分子診斷設備領域在預測期內將呈現最快的成長速度。這種成長是由於分子診斷在癌症和感染疾病早期檢測中的重要性日益增加。
  • 由於重複購買試劑，試劑在 2022 年獲得了最大的收益佔有率。
  • 2022年，北美將主導全球市場。對感染疾病治療的持續研究以及政府醫療機構隨後的津貼正在為該地區強大生態系統的發展做出貢獻。
  • 由於印度、中國和日本老年人口不斷增加，預計亞太地區將成為預測期內成長最快的地區。結果，結核病、霍亂、傷寒等感染疾病再次出現。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 臨床微生物學市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 臨床微生物學市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 臨床微生物：按產品估算和趨勢分析

  • 臨床微生物學市場：要點
  • 臨床微生物學市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 實驗室設備
    • 孵化器
    • 革蘭氏染色
    • 細菌菌落計數器
    • 高壓滅菌器
    • 培養皿填充物
  • 自動化文化
    • 微生物分析儀
    • 分子診斷設備
    • 顯微鏡
    • 質譜儀
  • 試劑

第5章 臨床微生物：依疾病分類的估計與趨勢分析

  • 臨床微生物學市場：要點
  • 臨床微生物學市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 呼吸系統疾病
  • 血流感染疾病
  • 消化系統疾病
  • 性行為感染傳染病
  • 尿道感染
  • 牙周
  • 其他疾病

第6章 臨床微生物學市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的臨床微生物學市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • BIOMERIEUX
    • Cepheid.
    • Danaher Corporation
    • Bruker Corporation
    • BD
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Alere, Inc.
Product Code: GVR-1-68038-142-9

Clinical Microbiology Market Growth & Trends:

The global clinical microbiology market size is expected to reach USD 7.6 billion by 2030, registering a CAGR of 7.1% during the forecast period, according to a new report by Grand View Research, Inc.. It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.

In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

Clinical Microbiology Market Report Highlights:

  • The molecular diagnostic instruments segment is expected to exhibit the fastest growth rate over the forecast period. This growth can be attributed to the increasing significance of molecular diagnosis in the early detection of cancer and infectious diseases.
  • Reagents captured the largest revenue share in 2022 owing to repeat purchase of reagents
  • In 2022, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Disease outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Microbiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Microbiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Clinical Microbiology : Product Estimates & Trend Analysis

  • 4.1. Clinical Microbiology Market: Key Takeaways
  • 4.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Laboratory Instruments
    • 4.3.1. Laboratory instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Incubators
      • 4.3.2.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Gram stainers
      • 4.3.3.1. Gram stainers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Bacterial colony counters
      • 4.3.4.1. Bacterial colony counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Autoclave sterilizers
      • 4.3.5.1. Autoclave sterilizers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Petri dish fillers
      • 4.3.6.1. Petri dish fillers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Automated Culture
    • 4.4.1. Automated culture market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Microbiology analyzers
      • 4.4.2.1. Microbiology analyzers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Molecular diagnostic instruments
      • 4.4.3.1. Molecular diagnostic instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Microscopes
      • 4.4.4.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Mass spectrometers
      • 4.4.5.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Microbiology: Disease Estimates & Trend Analysis

  • 5.1. Clinical Microbiology Market: Key Takeaways
  • 5.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Respiratory Diseases
    • 5.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Bloodstream Infections
    • 5.4.1. Bloodstream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Gastrointestinal Diseases
    • 5.5.1. Gastrointestinal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sexually Transmitted Diseases
    • 5.6.1. Sexually transmitted diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Urinary Tract Infections
    • 5.7.1. Urinary tract infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Periodontal Diseases
    • 5.8.1. Periodontal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Other Diseases
    • 5.9.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Microbiology Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Microbiology Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. BIOMERIEUX
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Cepheid.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Danaher Corporation
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bruker Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hologic, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. F. Hoffmann-La Roche Ltd
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Alere, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 14 UK clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 16 France clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 17 France clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Denmark clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Sweden clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 26 Norway clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 33 China clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 34 China clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 35 India clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 36 India clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 37 Australia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Thailand clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical microbiology market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical Microbiology: Market outlook
  • Fig. 9 Clinical Microbiology: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical microbiology market driver impact
  • Fig. 15 Clinical microbiology market restraint impact
  • Fig. 16 Clinical microbiology market strategic initiatives analysis
  • Fig. 17 Clinical microbiology market: Product movement analysis
  • Fig. 18 Clinical microbiology market: product outlook and key takeaways
  • Fig. 19 Laboratory instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Gram stainers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Bacterial colony counters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Autoclave sterilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Petri dish fillers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Automated culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Microbiology analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular diagnostic instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Microscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Mass spectrometers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clinical microbiology market: Disease movement analysis
  • Fig. 32 Clinical microbiology market: disease outlook and key takeaways
  • Fig. 33 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bloodstream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Gastrointestinal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sexually transmitted diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Urinary tract infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Periodontal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Other diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Global clinical microbiology market: Regional movement analysis
  • Fig. 41 Global clinical microbiology market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)